The Data Quality Illusion: Why Aggregated EHR Feeds Often Fail
In the life sciences industry, "lab data" is often treated as a commodity. The assumption is that a...
Tracking the Shift: Real-World Adoption of Emerging IHC Markers in Early 2026
Moving beyond the "hype" to seeing actual testing adoption on the ground.
The New Precision Oncology Battleground: Tracking FOLR1, CLDN18.2, and cMET
As Antibody-Drug Conjugates (ADCs) reshape the therapeutic landscape, commercial success depends on...
%20(1).png)
7 Best Practices for Lab Data Licensing: Maximize Value in Oncology & Genomics
By Jason Bhan, MD, Bill Paquin, Chris Hayes, Sundeep Bhan, Michael Cheyne [Bonus: Link to the free...
Decoding the Complexities of Breast Cancer Treatment: The Role of Lab Data & HCP Engagement
Breast cancer treatment is an intricate field, with ongoing research and development leading to...